Gilead Sciences, Inc. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Gilead Sciences with three other
pharmaceutical manufacturers in North America:
Bristol-Myers Squibb Company
sales of $22.56 billion
of which 21%
was Enbre), and
Gilead Sciences reported sales of $22.13 billion
December of 2018.
decrease of 15.2%
versus 2017, when the company's sales were $26.11 billion.